Calls
1
u/Adrian_TTV
Reddit r/stocks
Win Rate
100.0%
return
+36.2%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Feb 01
$1.99
+36.2%
The author argues Editas Medicine is a real CRISPR company with actual IP and ongoing eye and liver programs whose stock has been destroyed by dilution, biotech winter, and bad sentiment, leaving expectations near zero. Because the market cap is low, any positive development such as data, a partnership, or an asset sale could cause a hard repricing. The author frames this as high risk/high reward, noting it could bleed for a long time before suddenly moving, and claims a 10x is possible.
Construction & Infrastructure
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Adrian_TTV has 1 trade ideas tracked on Buzzberg across 1 tickers since February 2026. Most covered: EDIT.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
